50df13cd8c9cfa88ec41c56d3500e1c61196c5f6
graphic-right
overlay-bottom[1]
NEWS

Science, Stories & the Future of Genomics

For clinicians, patients, and the curious — insights on genomics, hereditary conditions, and the stories that remind us why this work matters.

Articles Tagged: Hereditary Cancer

67e5d74836ff3770926954
April 11, 2025

Don’t Miss the 1 in 4: Essential Hereditary Cancer Screening for OB/GYN Patients

699dd4c3b3231845853513
Caitlin Reid, Genomic Science Liaison, Ambry Genetics
Arlene Jacobs, MD, from Plano Women’s Healthcare shares how to reach patients at risk for hereditary cancer.
Genetic Testing
Hereditary Cancer
67587d2d5f3d6725792965
December 18, 2024

Enhancing Patient Care: A Digital Approach via The Ambry CARE Program® Improves Universal Cancer Risk Stratification in Imaging Centers

A retrospective study across 15 Imaging Centers assesses the transition of a paper screening cancer risk assessment tool to a universally accessible tool on a…
Genetic Testing
Hereditary Cancer
OBGYN
Screening
6760655a4f259482092722
December 17, 2024

Navigating Hereditary Cancer Testing: Selecting the Right Multigene Panel

For healthcare providers, choosing the right hereditary cancer test and laboratory is crucial to offer the best care for their patients.
Genetic Testing
Hereditary Cancer
Multigene Panel Testing
674df589ea8c1876967348
December 4, 2024

Understanding Gene-Disease Validity in Hereditary Cancer Testing

Gene-Disease Validity (GDV) discussed as an important concept for evaluating hereditary cancer multigene panel tests (MGPTs).
Genetic Testing
Hereditary Cancer
6759abb342e4b832985144
October 31, 2024

Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach

6216d56da94a5012935386
Jessica Grzybowski, Lead Genetic Counselor, Reporting – RNA, Ambry Genetics
Ambry’s balanced approach to designing hereditary cancer tests ensures our panels remain relevant and impactful, helping clinicians manage hereditary cancer risk with confidence.
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Variant of Unknown Significance
VUS
673e36d037903910413351
October 17, 2024

The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment

6480bd1fb8467209227170
Elizabeth Chao, Laboratory Director, Ambry Genetics
Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.
BRCA1 & 2
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Ovarian Cancer
Variant of Unknown Significance
VUS